Skip To Main Content
Denisse Barajas on Muck Rack

Denisse Barajas

As seen in: BMJ Open, RAND Corporation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Denisse

Contact Denisse, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Barriers and facilitators of habit building for long-term adherence to antihypertensive therapy among people with hypertensive disorders in Los Angeles, California: a qualitative study

|
By Ishita Ghai, Alina I. Palimaru, Joseph E. Ebinger, Denisse Barajas
| BMJ Open Verified
Abstract Objectives The aim of this study was to a) explore barriers and facilitators associated with medication-taking habit formation, and b) elicit feedback on the components of an intervention designed to help form strong habits for long-term medication adherence. Design The study design was qualitative; we conducted semistructured interviews between September 2021 and February 2022.
Open in Who Shared View Duplicates (2) Issue with article?

Behavioural Economics to Improve Antihypertensive Therapy Adherence (BETA)

|
By Joseph E. Ebinger, Denisse Barajas, Rocío Vallejo, Ciantel Blyler
| RAND Corporation
Introduction Non-adherence to antihypertensive therapy is one of the major barriers to reducing the risk of cardiovascular disease. Several interventions have targeted higher medication adherence, yet most do not result in sustained adherence. Routinisation has emerged as a potential method for mitigating this problem, but requires high motivation during the relatively long habit formation phase.
Open in Who Shared Issue with article?

Behavioural Economics to Improve Antihypertensive Therapy Adherence (BETA): protocol for a pilot randomised controlled trial in Los Angeles

|
By Joseph E. Ebinger, Ishita Ghai, Denisse Barajas, Rocío Vallejo
| BMJ Open Verified
Methods and analysis Study design This three-armed pilot randomised controlled trial (RCT) will last for nine months, with intervention administration for the first three months and a post-intervention follow-up for six months.
Open in Who Shared View Duplicates (2) Issue with article?
See all 3 articles